Form 4: Centene CFO Andrew Asher Boosts Stake with Equity Awards

Centene's Chief Financial Officer, Andrew Asher, reported the acquisition of 173,573 shares of common stock through equity awards, increasing his beneficial ownership to over 831,000 shares.

Summary

• Andrew Lynn Asher, Chief Financial Officer of Centene Corp (CNC), reported an acquisition of 173,573 shares of common stock on January 26, 2026, at a price of $0.
• The acquisition includes 69,429 restricted stock units (RSUs) set to vest in three annual installments beginning March 15, 2027.
• It also includes 104,144 performance stock units (PSUs) reported at target level performance, which will vest on March 15, 2029.
• The actual number of PSUs vesting can range from 0% to 200% of the target, based on Centene's stock price performance between the final 20 trading days of 2025 and the final 60 trading days of 2028.
• Following these transactions, Mr. Asher beneficially owns 831,215.48 shares of common stock, which includes 384,247 shares of previously-granted RSUs and PSUs subject to vesting.
• Mr. Asher also holds 13,449 common stock options with an exercise price of $81.85, granted on December 15, 2021, and expiring on December 15, 2031.
• These options may become exercisable on or after December 15, 2024, if Centene's common stock closing price equals or exceeds $100 per share for 20 consecutive trading days following the grant date.

Sentiment

Score: 7

Explanation: The filing indicates a significant acquisition of equity awards by a key executive, including performance-based incentives, which generally signals confidence in the company's future and aligns management interests with shareholders. This is a positive, though expected, event.

Positives

• The acquisition of 173,573 shares through equity awards by the Chief Financial Officer demonstrates increased insider alignment with shareholder interests.
• A significant portion of the new awards (104,144 performance stock units) is tied directly to the company's stock price performance, incentivizing management to drive share value.
• The total beneficial ownership of 831,215.48 shares, including vested and unvested awards, indicates a substantial stake held by a key executive.

Risks

• The actual number of performance stock units (PSUs) that will vest can range from 0% to 200% of the reported target, depending on Centene's stock price performance, introducing variability in executive compensation.
• The performance stock options are subject to a specific condition (CNC stock price reaching $100 for 20 consecutive trading days) to become exercisable, meaning they may not be realized if the condition is not met.

Future Outlook

The vesting schedules for the restricted stock units extend to March 2027 and beyond, while performance stock units are tied to stock price performance through the end of 2028, indicating a long-term incentive structure for the Chief Financial Officer. The exercisability of stock options is also contingent on future stock price performance.

Industry Context

This insider transaction reflects a standard practice of executive compensation within the healthcare services industry, where equity awards are used to align management incentives with long-term shareholder value creation. Performance-based vesting conditions are increasingly common to tie executive pay to company performance metrics.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) and performance stock units (PSUs) as a significant component of executive compensation is a common practice across the S&P 500 and particularly within the healthcare sector, aligning executive interests with long-term company performance.
• The performance conditions tied to stock price (e.g., for PSUs and stock options) are typical for large-cap companies like Centene, similar to compensation structures seen at peers such as UnitedHealth Group (UNH) or Anthem (now Elevance Health, ELV), which often link a portion of executive equity awards to relative or absolute total shareholder return metrics.
• The vesting schedule for RSUs over three annual installments is standard, providing retention incentives, while the 0-200% payout range for PSUs based on performance is a common design to offer upside potential for strong performance and downside risk for underperformance.

Stakeholder Impact

• Shareholders: Increased alignment of the Chief Financial Officer's interests with shareholder value due to significant equity ownership and performance-based awards.
• Employees: The compensation structure for a key executive may set a precedent or reflect broader compensation philosophies within the company.

Next Steps

• Vesting of 69,429 restricted stock units in three annual installments beginning March 15, 2027.
• Vesting of 104,144 performance stock units on March 15, 2029, contingent on stock price performance.
• Potential exercisability of 13,449 stock options on or after December 15, 2024, if Centene's stock price meets the $100 threshold for 20 consecutive trading days.

Key Dates

Recommendation

This Form 4 indicates a positive signal of insider alignment and confidence through the acquisition of equity awards by the CFO. While not a direct open market purchase, the performance-based nature of a significant portion of these awards ties executive compensation directly to future stock performance. This generally reinforces a 'hold' recommendation for existing investors, as it suggests management is incentivized to drive long-term value, but it doesn't present new fundamental information that would warrant a 'buy' or 'sell' solely based on this filing.

Keywords

Centene Corp, CNC, SEC Form 4, Insider Transaction, Equity Awards, Restricted Stock Units, Performance Stock Units, Stock Options, Chief Financial Officer, Executive Compensation, Beneficial Ownership